These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8522850)

  • 1. Efficacy and safety of alpha-interferon treatment for chronic hepatitis C in HIV-infected patients. HIV-Hepatitis Spanish Study Group.
    Soriano V; García-Samaniego J; Bravo R; Castro A; Odriozola PM; González J; Colmenero M; Carballo E; Suárez D; Llibre JM
    J Infect; 1995 Jul; 31(1):9-13. PubMed ID: 8522850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group.
    Soriano V; García-Samaniego J; Bravo R; González J; Castro A; Castilla J; Martínez-Odriozola P; Colmenero M; Carballo E; Suárez D; Rodríguez-Piñero FJ; Moreno A; del Romero J; Pedreira J; González-Lahoz J
    Clin Infect Dis; 1996 Sep; 23(3):585-91. PubMed ID: 8879784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of chronic hepatitis C with interferon in patients infected with the human immunodeficiency virus. The Spanish Group for the Study of Viral Hepatitis in HIV+ Patients].
    Soriano V; García-Samaniego J; Bravo R; González J; Castro A; Martńez-Odriozola P; Colmenero M; Carballo E; Suárez D; Castilla J; Rodriguez-Piñero FJ; Moreno A; del Romero J; Pedreira J; González-Lahoz J
    Med Clin (Barc); 1996 Apr; 106(13):486-90. PubMed ID: 8992129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of pegylated interferon alpha-2a therapy for chronic hepatitis C in HIV-infected patients with haemophilia.
    Zhang RF; Sun HQ; Huang Q; Wang JR; Zhang XX; Liu XN; Ma Q; Lu HZ
    Haemophilia; 2010 May; 16(3):502-7. PubMed ID: 20028427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.
    Dominguez S; Ghosn J; Valantin MA; Schruniger A; Simon A; Bonnard P; Caumes E; Pialoux G; Benhamou Y; Thibault V; Katlama C
    AIDS; 2006 May; 20(8):1157-61. PubMed ID: 16691067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of pegylated-interferon plus ribavirin in HIV-infected patients co-infected with hepatitis C virus in clinical practice: a 32 cases observational follow-up].
    Seydi M; Morlat P; Bonnet F; Rambeloarisoa J; Bernard N; Lacoste D; Bonarek M; Trimoulet P; Ramanampamonjy R; Lafon ME; Dramé M; Beylot J
    Rev Med Interne; 2005 Apr; 26(4):280-7. PubMed ID: 15820563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppression.
    Mira JA; Gutiérrez-Valencia A; Gil Ide L; Merino D; Rivero A; Ríos-Villegas MJ; Delgado M; González-Serrano M; Collado A; Torres-Tortosa M; Omar M; López-Ruz MA; Macías J; Arponen S; Pineda JA
    Clin Infect Dis; 2009 Oct; 49(8):e84-91. PubMed ID: 19772388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon alpha treatment of chronic hepatitis C in HIV-infected patients receiving zidovudine: efficacy, tolerance and response related factors.
    Del Pozo MA; Arias JR; Pinilla J; Labarga P; Alcoba M; Martinez de la Cruz FJ; Anton F; Carro JA; Perez MR; Echevarria S; Garrote E; Moreno-Otero R
    Hepatogastroenterology; 1998; 45(23):1695-701. PubMed ID: 9840131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B.
    Di Martino V; Thevenot T; Colin JF; Boyer N; Martinot M; Degos F; Coulaud JP; Vilde JL; Vachon F; Degott C; Valla D; Marcellin P
    Gastroenterology; 2002 Dec; 123(6):1812-22. PubMed ID: 12454838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy.
    Myers RP; Benhamou Y; Bochet M; Thibault V; Mehri D; Poynard T
    AIDS; 2004 Jan; 18(1):75-9. PubMed ID: 15090832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients.
    Castells L; Esteban JI; Bilbao I; Vargas V; Allende H; Ribera E; Piron M; Sauleda S; Len O; Pahissa A; Esteban R; Guardia J; Margarit C
    Antivir Ther; 2006; 11(8):1061-70. PubMed ID: 17302376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INCIDENCE OF TUBERCULOSIS AMONG HIV/HCV CO-INFECTED PATIENTS RECEIVING HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN IN GEORGIA.
    Abutidze A; Bolokadze N; Chkhartishvili N; Sharvadze L; Tsertsvadze T
    Georgian Med News; 2016 Mar; (252):10-5. PubMed ID: 27119828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of combination therapy with interferon-alpha2b and ribavirin for chronic hepatitis C in HIV-infected patients.
    Landau A; Batisse D; Duong Van Huyen JP; Piketty C; Bloch F; Pialoux G; Belec L; Petite JP; Weiss L; Kazatchkine MD
    AIDS; 2000 May; 14(7):839-44. PubMed ID: 10839592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of condylomata acuminata with pegylated interferon alfa-2b in HIV-infected patients.
    Brockmeyer NH; Poffhoff A; Bader A; Hochdorfer B; Schlottmann R; Rasokat H; Altmeyer P; Kreuter A
    Eur J Med Res; 2006 Jan; 11(1):27-32. PubMed ID: 16504957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.
    Santin M; Shaw E; Garcia MJ; Delejido A; de Castro ER; Rota R; Altés J; Baguena F; Valero S; Sala M; Casanova A;
    AIDS Res Hum Retroviruses; 2006 Apr; 22(4):315-20. PubMed ID: 16623633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical efficacy of pegylated interferon in patients co-infected with HIV and HCV who failed standard interferon therapy].
    Ke YC; Li LH; Hu FY; He Y; Lan Y; Chen XJ; Tang XP; Cai WP
    Zhonghua Gan Zang Bing Za Zhi; 2016 Mar; 24(3):181-5. PubMed ID: 27095760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutical aspects and outcome of HIV/HCV coinfected patients treated with pegylated interferon plus ribavirin in an Italian cohort.
    Righi E; Beltrame A; Bassetti M; Lindstrom V; Mazzarello G; Dentone C; Di Biagio A; Ratto S; Viscoli C
    Infection; 2008 Aug; 36(4):358-61. PubMed ID: 18642111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic hepatitis D with interferon alpha-2b in patients with human immunodeficiency virus infection.
    Puoti M; Rossi S; Forleo MA; Zaltron S; Spinetti A; Putzolu V; Rodella A; Carosi G
    J Hepatol; 1998 Jul; 29(1):45-52. PubMed ID: 9696491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T-lymphocytopenia in HIV-infected patients receiving interferon therapy for chronic hepatitis C. HIV-Hepatitis Spanish Study Group.
    Soriano V; Bravo R; Samaniego JG; González J; Odriozola PM; Arroyo E; Vicario JL; Castro A; Colmenero M; Carballo E
    AIDS; 1994 Nov; 8(11):1621-2. PubMed ID: 7848601
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report.
    Zylberberg H; Benhamou Y; Lagneaux JL; Landau A; Chaix ML; Fontaine H; Bochet M; Poynard T; Katlama C; Pialoux G; Bréchot C; Pol S
    Gut; 2000 Nov; 47(5):694-7. PubMed ID: 11034587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.